| 澳亚集团 |
Rive Naomi Julia |
增持 |
307598171 |
30759.82万股 |
0.44% |
好仓 |
2022-12-30 |
| 澳亚集团 |
Hall Martin John |
增持 |
307598171 |
30759.82万股 |
0.44% |
好仓 |
2022-12-30 |
| 特海国际 |
Futu Trustee Limited |
增持 |
61933000 |
6193.30万股 |
0.10% |
好仓 |
2022-12-30 |
| 澳亚集团 |
Hall Martin John |
增持 |
295894133 |
29589.41万股 |
0.42% |
好仓 |
2022-12-30 |
| 澳亚集团 |
Rive Naomi Julia |
增持 |
295894133 |
29589.41万股 |
0.42% |
好仓 |
2022-12-30 |
| 澳亚集团 |
Highvern Trustees Limited |
增持 |
295894133 |
29589.41万股 |
0.42% |
好仓 |
2022-12-30 |
| 澳亚集团 |
MNM Holdings Limited |
增持 |
295894133 |
29589.41万股 |
0.42% |
好仓 |
2022-12-30 |
| 澳亚集团 |
陈荣南 |
增持 |
28140581 |
2814.06万股 |
0.04% |
好仓 |
2022-12-30 |
| 澳亚集团 |
陈荣南 |
增持 |
28140581 |
2814.06万股 |
0.04% |
好仓 |
2022-12-30 |
| 康沣生物-B |
Hangzhou Proxima Innovative Investment L.P. (Limited Partnership) (杭州比邻星创新投资合夥企业(有限合夥)) |
增持 |
8047944 |
804.79万股 |
0.07% |
好仓 |
2022-12-30 |
| 康沣生物-B |
Hangzhou Proxima Innovative Investment Management L.P. (Limited Partnership) (杭州比邻星创新投资管理合夥企业(有限合夥)) |
增持 |
10317388 |
1031.74万股 |
0.09% |
好仓 |
2022-12-30 |
| 康沣生物-B |
Ningbo Linfeng Biotechnology Co., Ltd. (宁波麟沣生物科技有限公司) |
增持 |
30730616 |
3073.06万股 |
0.27% |
好仓 |
2022-12-30 |
| 康沣生物-B |
孙晓路 |
增持 |
10317388 |
1031.74万股 |
0.09% |
好仓 |
2022-12-30 |
| 澳亚集团 |
Santosa Renaldo |
增持 |
247635035 |
24763.50万股 |
0.35% |
好仓 |
2022-12-30 |
| 澳亚集团 |
Santosa Gabriella |
增持 |
247278175 |
24727.82万股 |
0.35% |
好仓 |
2022-12-30 |
| 澳亚集团 |
Rangi Management Limited |
增持 |
212395300 |
21239.53万股 |
0.30% |
好仓 |
2022-12-30 |
| 澳亚集团 |
Fusion Investment Holdings Limited |
增持 |
212395300 |
21239.53万股 |
0.30% |
好仓 |
2022-12-30 |
| 澳亚集团 |
MNM Holdings Limited |
增持 |
307598171 |
30759.82万股 |
0.44% |
好仓 |
2022-12-30 |
| 澳亚集团 |
Highvern Trustees Limited |
增持 |
307598171 |
30759.82万股 |
0.44% |
好仓 |
2022-12-30 |
| 天润云 |
TI YUN Limited |
减持 |
-7324048 |
1922.60万股 |
0.11% |
好仓 |
2022-12-30 |
